Researchers presented these bladder cancer study findings at the 117th Annual Scientific Meeting of the American Urological Association (AUA)
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
India has the second-largest number of adults with diabetes globally, after China
The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams
With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
Cipla has reported consolidated financial results for the period ended March 31, 2022
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt
The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali
Subscribe To Our Newsletter & Stay Updated
